Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Resistance, Neoplasm | 3 | 2024 | 5305 | 0.430 |
Why?
|
Neoplasms | 9 | 2024 | 22164 | 0.410 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2019 | 0.290 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6339 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3602 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2023 | 3639 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5302 | 0.230 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9418 | 0.230 |
Why?
|
Mutation | 11 | 2024 | 30045 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 214 | 0.220 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 101 | 0.200 |
Why?
|
Hematology | 1 | 2023 | 244 | 0.160 |
Why?
|
Mice, SCID | 1 | 2024 | 2626 | 0.160 |
Why?
|
Nevus, Blue | 1 | 2019 | 43 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 552 | 0.160 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2019 | 102 | 0.160 |
Why?
|
Tumor Burden | 1 | 2024 | 1890 | 0.160 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13337 | 0.150 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 782 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 4 | 2024 | 5665 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1365 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1664 | 0.110 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2811 | 0.110 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1896 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.090 |
Why?
|
Genome, Human | 1 | 2023 | 4425 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2019 | 2448 | 0.090 |
Why?
|
Humans | 21 | 2024 | 761423 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4876 | 0.070 |
Why?
|
Middle Aged | 8 | 2024 | 220826 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58956 | 0.060 |
Why?
|
Ascitic Fluid | 1 | 2023 | 189 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13502 | 0.050 |
Why?
|
Female | 9 | 2024 | 392581 | 0.050 |
Why?
|
Aged | 6 | 2024 | 169235 | 0.050 |
Why?
|
Adult | 5 | 2024 | 221148 | 0.050 |
Why?
|
Quinoxalines | 1 | 2024 | 296 | 0.050 |
Why?
|
Prospective Studies | 5 | 2024 | 54415 | 0.050 |
Why?
|
Ascites | 1 | 2023 | 338 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 581 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20556 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 80582 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9277 | 0.050 |
Why?
|
Melanoma | 1 | 2019 | 5709 | 0.040 |
Why?
|
Mice | 2 | 2024 | 81509 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2024 | 716 | 0.040 |
Why?
|
Acrylamides | 1 | 2022 | 259 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5819 | 0.040 |
Why?
|
Genomic Instability | 1 | 2023 | 709 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 898 | 0.040 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 605 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2023 | 805 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1125 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1745 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1155 | 0.030 |
Why?
|
Signal Transduction | 1 | 2020 | 23441 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2510 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1076 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2022 | 1069 | 0.030 |
Why?
|
Male | 5 | 2024 | 360736 | 0.030 |
Why?
|
Animals | 2 | 2024 | 168441 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2057 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2007 | 0.030 |
Why?
|
United States | 1 | 2022 | 72339 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2863 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1743 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4912 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29620 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6086 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3027 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2054 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2914 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5311 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7219 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16979 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5820 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4320 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12125 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59207 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 64651 | 0.010 |
Why?
|
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_